Gentamycin
23 brands · 16 companies · product forms
Opportunity snapshot
Who competes here
Top companies by brand count — fragmented market (no dominant player) · leader share 13%
Price room
max/min price ratio 78.26x across 32 trusted points (Rs 17.02-1332.01). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.
Brands & products on the market
Sample of 8 live products for Gentamycin — each links to its own medicine page.
Regulatory alerts
Why this score
Launch attractiveness
40% supply-gap(20) + 25% price-variation(100) + 20% low-competition(58) + 15% supply-disruption(40), damped by confidence(90). Higher = more attractive, less crowded opportunity.
Market saturation
16 canonical companies and 23 brands compete (saturation pegged at 30 companies / 150 brands).
Price room
max/min price ratio 78.26x across 32 trusted points (Rs 17.02-1332.01). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.
Regulatory risk
1 DRAP alert(s), latest 2023-04-05 incl. recall/safety.
Confidence
Reduced by: no ATC code.
Packaged brief for this moderate opportunity?
Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.
See packaged reports All 3868 molecules